MedTrace Logo

Drug Use and Ultra-endurance Race

NCT03402022 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2923

Last updated 2018-01-17

No results posted yet for this study

Summary

Hypothesis: To verify whether the use of drugs, in particular performance-enhancing drugs, is prevalent amongst participants in a very long distance mountain trail.

Primary objective : To qualify and quantify drug use amongst participants in a very long distance mountain trail, by targeting the molecules most likely used by the runners.

Conditions

  • Healthy Individuals

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Pierre BOUZAT, Dr · University Hospital, Grenoble

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-30
Primary Completion
2017-12-15
Completion
2017-12-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03402022 on ClinicalTrials.gov